About Us
The British Association for Cytopathology (BAC) was formed in 2011 following the merger of the British Society for Clinical Cytology (BSCC) and the National Association of Cytologists (NAC)
The aims and objectives of the Association are:
To encourage the science and art of Cytopathology by encouraging higher standards in Cytopathology for the benefit of the public
To encourage research in Cytopathology and related fields and the publication of useful results
In line with these aims, the BAC acknowledge the importance of training and education as helping develop the cytology workforce in delivering a high quality and clinically relevant cytology service. Any training and education must build on the core skills that cytologists, whatever their route into cytology, acquire in basic training leading to development throughout their professional lives.
The BAC is the voice for cytology on numerous stakeholder professional groups. This list is not exhaustive but includes: the NHS Cervical Screening Programme, the Department of Health, Royal College of Pathologists, Institute of Biomedical Science, European Federation of Cytology Societies and worldwide through the International Academy of Cytology.
Communication with other bodies occurs primarily through the elected Executive. If there are any issues of importance that you feel the BAC should address, please address your views to the Honorary Secretary.
The BAC acts as the primary owner of and major contributor to guidelines which bear on the practice of both cervical and diagnostic cytopathology. The BAC also inputs via representation on other bodies into national workforce and educational discussions, to help shape the UK approach to these topics.
Cytopathology is the official journal of the British Association for Cytopathology.
-
The Team
-
President of the BAC, Consultant cellular pathologist at West Hertfordshire Teaching Hospitals NHS Trust
Dr Anthony Maddox
Reporting a full range of diagnostic cytopathology samples as well as histopathological biopsies of lung.
Interested in the provision of Rapid Onsite Evaluation (ROSE) as a tool for maximising the benefit of needle aspirates in thoracic, pancreatic and head and neck disease and in promoting the involvement of biomedical scientists in that process.
Elected: AGM 2023
-
Chair of the BAC, Consultant Biomedical Scientist in Cervical Cytology at NHS Lothian and NHS Lanarkshire
Sue Mehew
Director of Scottish Cytology Training School. Specialist interests in teaching cervical cytology, the psychology of cytology screening, invasive cervical cancer audit plus BMS reporting of gynaecological histopathology.
Ask a questionElected: AGM 2023
-
Honorary Secretary and CEC lead for BAC, Consultant Biomedical Scientist in cervical Cytology, Bristol Southmead
Helen Burrell
Ask a questionElected: AGM 2023
-
Consultant Biomedical Scientist and Laboratory Manager at Monklands Hospital
Professor Allan Wilson
Clinical Lead for the Scottish Cervical Screening Programme.
Professor Wilson has been working in Cytology since 1976 and has a special interest in screening, molecular testing, invasive cancer audit and digital cytology. He is a member of the UK National Screening Committee and Visiting Professor at Robert Gordon University.
Elected: AGM 2023
-
Consultant Histopathologist and Cytopathologist - Guy’s and St Thomas’s, London
Dr Ash Chandra
Specialist interest in cytopathology education, reporting terminologies, FNA and ROSE
Ask a questionElected: AGM 2023
-
Membership Lead and Consultant Cytopathologist at Guy’s and St Thomas’ Hospital, London
Dr Martina Munonyara
Specialist interests includes Diagnostic cytopathology including ROSE (EBUS, EUS and one-stop clinics), Thoracic Pathology and education
Her special interest is teaching, in which she has delivered tutorials for the London Deanery, Path Soc Winter school and the BAC ASM.
Elected: AGM 2024
-
Media lead for the BAC, Consultant Biomedical Scientist in diagnostic cytopathology, Royal Cornwall Hospital
Mrs Leonie Wheeldon
Consultant Biomedical Scientist reporting diagnostic cytopathology. Specialist interest and expertise in rapid on-site evaluation.
Member of the IBMS advisory panel for Cytopathology and the Cytopathology Journal media team.
Elected: AGM 2023
-
Advanced Biomedical Scientist, Royal Victoria Infirmary
Donna Morrison
Diagnostic cytology and Quality in cytology
Ask a questionElected: AGM 2023
-
Specialist Biomedical Scientist and Trainee Clinical Scientist in Cytology and Andrology at Queen Alexandra Hospital in Portsmouth
Karina Evans
Interests in diagnostic cytology
Ask a questionElected: AGM 2023
-
Advanced Practitioner, Pathlinks, Northern Lincolnshire & Goole Hospitals NHS Foundation Trust
Sue Smith
Ask a questionElected: AGM 2023
-
Consultant Biomedical Scientist, Manchester University NHS Foundation Trust
Antonia Tweed
Specialist interests: Gynae cytopathology and training
Ask a questionElected: AGM 2023
-
Cytopathology Associate Editor, SCAN
Hedley Glencross (co-opted)
Retired Biomedical Scientist
-
Editor, Cytopathology
Professor Philippe Vielh (co-opted)
-
Professional Support Services Manager (IBMS)
Christian Burt
20 years membership body experience and provider of support service functions for the BAC.
-
Consultant Biomedical Scientist and the Cervical Cancer Audit Lead
Angela Brown
Quality assurance in the cervical screening programme, cervical glandular abnormalities and the cervical cancer audit process
Ask a questionElected: AGM 2024
-
BAC Representation on external groups
-
-
-
RCPath Cytopathology SAC
Dr Anthony Maddox
Royal College of Pathologists – Cytopathology Sub committee
Ask a question -
CSET CPG
Miss Helen Burrell
cervical screening education and training clinical professional group
Ask a question -
-
-
RCPath Cytopathology representative
Dr Anthony Maddox
Royal College of Pathologists representative
Ask a question